Related by context. All words. (Click for frequent words.) 69 postmarket surveillance 68 postapproval 67 myopathy rhabdomyolysis 66 non selective NSAIDs 64 Vimpat R 64 postmarketing 64 clevidipine 63 LEVAQUIN 63 neuropsychiatric symptoms 63 antiarrhythmic drug 63 placebo controlled studies 62 cardiac toxicity 62 antiepileptics 62 intravenous bisphosphonates 62 PrandiMet TM 62 Celebrex celecoxib 62 SILENOR 62 severe hypersensitivity reactions 62 alvimopan 62 TQT studies 62 QT prolongation 62 empiric therapy 62 SPIRIVA HandiHaler 62 REMINYL ® 62 ARCOXIA 62 randomized controlled clinical trials 61 Tracleer R 61 paliperidone ER 61 REG1 61 piroxicam 61 topical diclofenac 61 methodological limitations 61 Candesartan 61 oral anticoagulation 61 QTc prolongation 61 SPARLON 61 PROVIGIL 61 eculizumab therapy 61 antiplatelet medications 61 GnRH agonists 61 INTELENCE 61 renal toxicity 61 RISPERDAL ® 61 topical NSAIDs 61 rFVIIa 61 antiplatelet drugs 61 INVEGA ® 60 Warfarin Coumadin 60 cardiac repolarization 60 ranolazine 60 LDTs 60 tolerability profiles 60 Protelos 60 BANZEL 60 ZOLINZA 60 selective NSAIDs 60 paliperidone 60 PDE4 inhibitors 60 Arranon 60 GSK Avandia 60 paroxetine Seroxat 60 TREDAPTIVE 60 thorough QT 60 VTE prophylaxis 60 liver toxicity 60 Hepatotoxicity 60 riociguat 60 antimicrobial prophylaxis 60 PRADAXA 60 pharmacokinetic interactions 60 Tardive dyskinesia 60 QTc intervals 60 MYCAMINE 60 INTEGRILIN 60 Potiga 60 MERLIN TIMI 60 cerivastatin 60 posaconazole 60 bovine thrombin 60 Quetiapine 60 statin medications 60 hypersensitivity allergic reactions 60 neuropsychiatric events 60 LEVAQUIN ® 59 Sanofi Acomplia 59 postmarket studies 59 RX ACCULINK 59 EXALGO 59 Torsades de Pointes 59 aripiprazole Abilify 59 FDA Adverse Event 59 hepatotoxicity 59 prucalopride 59 Thalomid ® 59 EMBEDA ™ 59 efalizumab 59 MAA submission 59 balsalazide tablet 59 DACH platinum 59 Embolic Protection Device 59 lomitapide 59 PREZISTA r 59 nephrotoxicity 59 gemifloxacin 59 ICH guidelines 59 Mitigation Strategy REMS 59 CRMD# 59 Postmarketing 59 ACIPHEX 59 somatostatin analogues 59 Sycrest 59 muraglitazar 59 gepirone ER 59 phase IIIb 59 thromboembolic events 59 AVERROES 59 Avandia rosiglitazone 59 tegaserod 59 cobiprostone 59 efficacy tolerability 59 postmarketing adverse 59 mitochondrial toxicity 59 RoACTEMRA 59 canakinumab 59 MGCD# clinical trials 59 MEVACOR 59 coadministration 59 antiarrhythmic 59 CIMZIA ™ 59 etravirine 59 sitaxsentan 59 panitumumab Vectibix 59 AZILECT ® 59 favorable tolerability 59 atypical femur fractures 59 ULORIC 59 trials RCTs 59 synthetic retinoid 59 antineoplastic 59 PRISTIQ 59 hepatic toxicity 59 Cimzia R 59 dopaminergic therapy 59 Azedra 59 postoperative ileus POI 59 Vernakalant 59 teriflunomide 59 Aprotinin 59 meta analyzes 59 MGN# 59 preclinical efficacy 59 AVANDIA 59 vaginal lidocaine 59 vosaroxin 59 antiresorptive 59 urate lowering 59 anti androgens 59 Anti Bacterial Envelope 59 Topiramate 59 COX 2s 59 Effexor venlafaxine 59 pimozide 59 HMG CoA reductase inhibitors 59 torsemide ER 59 Rasilez Tekturna 59 symptomatic paroxysmal AF 59 SJS TEN 59 selenium supplementation 59 paliperidone palmitate 59 Focalin XR 59 Valdoxan 59 clinical pharmacology studies 59 ADAGIO study 59 ORENCIA R 59 Advagraf 59 KRAS status 58 nonhematologic adverse reactions 58 BeneFIX 58 exploratory endpoints 58 NDA resubmission 58 teratogenicity 58 Aptivus 58 Meta analyzes 58 β blockers 58 TRISENOX 58 coxib 58 oral NSAIDs 58 NOXAFIL 58 mycophenolate mofetil 58 YONDELIS 58 Boxed Warning 58 dyslipidemias 58 Rofecoxib 58 SNRI 58 brivaracetam 58 tiagabine 58 antithrombotic agents 58 lipid lowering agents 58 UCB Cimzia 58 Cimzia TM 58 Starlix 58 BRILINTA 58 APTIMA HPV assay 58 potentially hepatotoxic 58 oral rivaroxaban 58 adjunctively 58 thrombolytic agents 58 hormone therapy HT 58 Androxal TM 58 pharmacologic stress 58 antihypertensive therapy 58 Zometa zoledronic acid 58 ISTODAX 58 MoxDuo IR 58 Raptiva ® 58 placebo controlled trials 58 ibandronate 58 antithrombotic therapy 58 olanzapine LAI 58 antiplatelet therapies 58 Product Characteristics 58 APTIVUS 58 anti arrhythmic 58 immune modulating 58 pitavastatin 58 CAPHOSOL 58 PLAVIX ® 58 antithrombotics 58 tardive dyskinesia TD 58 LATUDA 58 AdreView 58 Perforomist ™ Inhalation Solution 58 ziconotide 58 SPRIX ® 58 #D#C# 58 CYP#A# inhibitor 58 valdecoxib 58 injectable formulations 58 INFERGEN 58 NATRECOR R 58 APTIVUS r 58 JAK inhibitor 58 cardiac valvulopathy 58 Symbicort SMART 58 HCV protease inhibitors 58 thromboembolic disease 58 MAGE A3 ASCI 58 RIGScan CR 58 KAPIDEX 58 primidone 58 Paliperidone ER 58 prospective observational studies 58 Paxil paroxetine 58 ZOMIG 58 DAPT 58 acitretin 58 selective modulator 58 Fibrillex TM 58 EXJADE 58 cinacalcet 58 JANUMET 58 biologic DMARDs 58 pharmacodynamic parameters 58 Dasatinib 58 KAPVAY ™ 58 serotonin reuptake inhibitors 58 FDAAA 58 antibiotic prophylaxis 58 glatiramer acetate 58 antidiabetic drugs 58 histamine dihydrochloride 58 thromboprophylaxis 58 immunosuppressive therapies 58 adalimumab Humira 58 nonvertebral fracture 58 antiepileptic drug 58 Vectibix panitumumab 58 AST ALT 58 LibiGel ® 58 NeutroSpec 58 Serdolect ® 58 coxibs 58 Fortical R 58 Diovan HCT 58 CB1 antagonists 58 pulls Darvon painkiller 58 surrogate endpoint 58 icatibant 58 Azathioprine 58 Prosaptide 58 Novartis Reclast 58 Lixivaptan 58 Resolute DES 58 pain palliation 58 Afatinib 58 Known hypersensitivity 58 abatacept 58 antidiabetic medications 58 Keppra XR 58 Doribax 58 APTIVUS ritonavir 58 Actimmune ® 58 TYZEKA 58 CINQUIL 58 TriRima 58 Genzyme Myozyme 58 dosage regimen 57 Rapaflo 57 nesiritide 57 haematologic 57 oral prodrug 57 DNAwithPap TM Test 57 IONSYS TM 57 FACTIVE tablets 57 Tolvaptan 57 placebo controlled clinical trials 57 risperidone Risperdal 57 Adverse Event 57 SUTENT ® 57 GFT# 57 thrombotic events 57 bioequivalency 57 Dacogen injection 57 Phase IIIb study 57 eprodisate Fibrillex TM 57 AZILECT R 57 heparin induced thrombocytopenia 57 pulmonary toxicity 57 Vimpat lacosamide 57 FDAs 57 strontium ranelate 57 postmarketing studies 57 pemetrexed Alimta 57 Tekamlo 57 paroxetine Paxil 57 neuroleptics 57 desvenlafaxine succinate 57 multidose 57 vernakalant hydrochloride 57 HAART regimens 57 topiramate Topamax 57 Velcade bortezomib 57 ticagrelor Brilinta 57 SAPHRIS 57 oral anticoagulants 57 CYPHER R Sirolimus eluting 57 immunosuppressant therapy 57 SERMs 57 MULTAQ 57 oxcarbazepine 57 fusion enhancers 57 topical calcineurin inhibitors 57 tipranavir 57 vasomotor symptoms 57 Nesiritide 57 ATACAND 57 hematological toxicity 57 SANVAR 57 corticosteroid therapy 57 serotonin norepinephrine reuptake inhibitor 57 Vidaza azacitidine 57 PEARL SC 57 renal denervation 57 TWYNSTA ® 57 newer atypical antipsychotics 57 QT QTc 57 TORISEL 57 TNF alpha inhibitor 57 hypercalcemia 57 proton pump inhibitors PPIs 57 PRT# 57 Targretin capsules 57 motesanib 57 EDARBI 57 indiplon capsules 57 memantine Namenda 57 LYSTEDA 57 flecainide 57 Myfortic 57 CNS depressant 57 cefepime 57 serum phosphorous 57 PREOS 57 colorectal liver metastases 57 antithrombotic therapies 57 parecoxib 57 AGGRASTAT R 57 VNS Therapy TM 57 Dose adjustments 57 confirmatory clinical 57 nitrofurantoin 57 Linjeta TM 57 Neupro R 57 nefazodone 57 CYP #A# 57 menadione 57 Lorqess 57 THALOMID 57 multicenter clinical trials 57 FASLODEX 57 ginkgo extract 57 uric acid lowering 57 eprotirome 57 Cardiopulmonary bypass 57 prospective multicentre 57 Adalimumab 57 oral diclofenac 57 Selective Serotonin Reuptake Inhibitor 57 systemic immunosuppressive drugs 57 delipidation 57 balsalazide 57 Triapine R 57 gadobutrol 57 Plenaxis R 57 TYGACIL 57 erythropoietic 57 dorzolamide 57 Bridion 57 PROactive study 57 histone deacetylase inhibitor 57 VAPRISOL 57 gastrointestinal absorption 57 antiepileptic 57 Traficet EN 57 Ereska 57 Rythmol SR 57 APPRAISE 57 rosiglitazone Avandia 57 NSAID therapy 57 cardiac conduction 57 Genz # 57 Egrifta 57 CAELYX 57 desmopressin 57 Metozolv ODT 57 Levetiracetam 57 sibutramine Meridia 57 oral anticoagulant 57 NEUPOGEN 57 REOPRO 57 infliximab Remicade 57 Emselex 57 genotypic resistance 57 neuroleptic 57 gabapentin Neurontin 57 Exforge HCT 57 reboxetine 57 DEFINITY ® 57 Increlex R 57 Erythropoiesis stimulating agents 57 EFFEXOR XR 57 clinical trials 57 raloxifene Evista 57 Zelapar 57 FDA reviewers 57 developmental neurotoxicity 57 pegnivacogin 57 VA# [002] 57 pharmacokinetic profiles 57 novel oral anticoagulant 57 antiepileptic drugs 57 glitazones 57 noscapine 57 ACCORD Lipid 57 Spiriva Handihaler 57 opioid analgesia 57 biphosphonates 57 favorable pharmacokinetic profile 57 visilizumab 57 lacosamide 57 Catena ® 57 tecarfarin 57 cardiovascular ischemic 57 QT interval prolongation 57 TAXUS TM 57 ARIXTRA 57 Xinlay 57 cediranib 57 methylphenidate Ritalin 57 TMS Therapy 57 ganaxolone 57 anti leukemic 57 MGd 57 Pemetrexed 57 methodologically rigorous 56 anti resorptive 56 coronary intervention 56 prasugrel Effient 56 DEFINITY R 56 Dynastat 56 PLAVIX 56 adrenal suppression 56 pioglitazone Actos 56 NATRECOR ® 56 MMP inhibitors 56 NEXTERONE 56 biologic DMARD 56 troglitazone 56 AZX# 56 intravenous cyclophosphamide 56 cangrelor 56 Zenvia Phase III 56 ALVESCO HFA 56 Teriparatide 56 Icatibant 56 mycophenolate mofetil MMF 56 Lamotrigine 56 aspirin clopidogrel 56 eptifibatide 56 Subgroup analyzes 56 SCH # 56 venous thromboembolic disease 56 ACTEMRA 56 nucleoside analogs 56 galantamine 56 RezularTM 56 pharmacodynamic endpoints 56 Lofexidine 56 antimuscarinic 56 TYSABRI natalizumab 56 Dabigatran 56 Adverse Event Reporting 56 Tracleer r 56 inhibiting platelet activation 56 Neurodex 56 Zemplar Capsules 56 pharmacokinetic interaction 56 direct thrombin inhibitors 56 selective COX 2 56 oxymorphone ER 56 dual antiplatelet 56 Hydroxyurea 56 levosimendan 56 glatiramer 56 elagolix 56 budesonide foam 56 statins cholesterol lowering 56 VFEND 56 liver transaminases 56 AChE inhibitors 56 Xyrem ® 56 Bifeprunox 56 fosbretabulin 56 Octreolin 56 hypersensitivity reactions 56 renoprotective 56 levetiracetam Keppra 56 dexanabinol 56 HuMax EGFr 56 motavizumab 56 Vaprisol 56 ADME properties 56 antidepressive 56 natalizumab 56 AERx iDMS 56 Prozac fluoxetine 56 treat dysmenorrhea 56 thalidomide Thalomid 56 MYLOTARG 56 STRIDE PD 56 Firazyr 56 ROTARIX 56 BLA filing 56 UPLYSO 56 surrogate markers 56 Keppra R 56 adenosine injection 56 aleglitazar 56 ASPIRE HIGHER 56 carotid stents 56 amifostine 56 reslizumab 56 Zevalin consolidation 56 newer atypical antipsychotic 56 LHRH antagonists 56 Anzemet 56 optimal dosing 56 postmarket safety 56 Thorough QT 56 Zavesca r 56 Cellegesic 56 VIBATIV 56 Tarceva TM 56 Keppra ® 56 ARIXTRA R 56 PREVENT IV 56 immunosuppressive agents 56 EEG abnormalities 56 Zyprexa LAI 56 pharmacologic treatments 56 ADVANCE PD 56 Liver toxicity 56 toxicological studies 56 Pyridorin 56 FRAGMIN 56 Spiriva HandiHaler 56 Regranex 56 subgroup analyzes 56 AGILECT ® 56 proton pump inhibitor PPI 56 Stedivaze 56 Diamyd r vaccine 56 randomized controlled trials RCTs 56 divalproex sodium 56 pharmacotherapies 56 Xanafide 56 BioSTAR R 56 alpha interferons 56 chemoprevention trials 56 Orthokine 56 TOPROL XL 56 droperidol 56 Mylotarg 56 phase IIb trial 56 pharmacogenetic testing 56 Plicera 56 heterozygous FH 56 cardio renal 56 drug eluting coronary stents 56 AGHD 56 TELINTRA 56 casopitant 56 lipid lowering therapy 56 plasma kallikrein inhibitor 56 Ramelteon 56 PML progressive multifocal 56 guanfacine extended release 56 PROCRIT 56 Uloric 56 Cipralex ® 56 alemtuzumab MS 56 antibiotic Ketek 56 mGlu2 3 56 QNEXA 56 tricyclic antidepressant 56 orphan medicinal 56 Elitek 56 nalbuphine ER 56 anti androgen 56 dosage regimens 56 opioid bowel dysfunction 56 triglyceride lowering 56 preoperative MRI 56 trastuzumab Herceptin ® 56 antiplatelet agent 56 omeprazole Prilosec 56 Entereg R 56 Tredaptive 56 Eraxis 56 darunavir r 56 temsirolimus 56 Romiplostim 56 potency selectivity 56 rt PA 56 vasogenic edema 56 Q#IR 56 Visipaque 56 rosiglitazone 56 fluoxetine Prozac 56 lucinactant 56 antithrombotic 56 6R BH4 56 NeuroStar TMS Therapy 56 atypical antipsychotic medications 56 analgesic medications 56 VALOR trial 56 carcinogenicity studies 56 dronedarone 56 Prostate AdenoCarcinoma Treatment 56 Carvedilol 56 LOVENOX R 56 adalimumab 56 therapeutic equivalence 56 Lp PLA 2 56 GAMMAGARD 56 alpha blocker 56 pharmacodynamics PD 56 anticholinergic agents 56 antidepressants fluoxetine 56 generalisability 56 tumor necrosis 56 RAPAMUNE 56 NUCYNTA R 56 Entereg 56 CONCERTA 56 Serious Adverse Events 56 poststroke depression 56 Option IVC Filter 56 etanercept Enbrel 56 biologic plausibility 56 anticoagulation therapy 56 pioglitazone HCl 56 Notified Bodies 56 telithromycin 56 colon capsule endoscopy 56 GP IIb IIIa inhibitors 56 multicenter trials 56 CINTREDEKIN BESUDOTOX 56 nonclinical studies 56 pulmonary artery banding 56 clinically meaningful efficacy 56 Zavesca R 56 carbidopa levodopa 56 VADT 56 inhibit platelet function 56 COPD exacerbations 56 DEXILANT 56 BAL# [002] 56 phase IIb clinical 56 Removab 56 dose proportionality 56 NIASPAN 56 EMBEDA TM 56 Torisel 56 AQUAVAN R 56 CERVARIX 56 cartilage degeneration 56 fluoroquinolone antibiotic 56 Botox Botox Cosmetic 56 Pentacel vaccine 56 endothelin receptor antagonists 56 adipiplon 56 radiographic outcomes 56 RSD# 56 Ambrisentan 56 Alvesco R 56 Pennsaid R 56 sipuleucel T 56 Navelbine ® 56 XOPENEX Inhalation Solution 56 pharmacokinetic studies 56 STEP BD 56 genotoxicity 56 ISENTRESS 56 PROMACTA 56 Avandia Actos 56 ONTARGET 56 BEXXAR 55 MMRV vaccine 55 severe gastroparesis 55 Hyphanox 55 methylnaltrexone 55 r hGH 55 Novartis Gilenya 55 rosiglitazone maleate 55 ezogabine 55 NanoCrystal Technology 55 maximally tolerated dose 55 morphometric vertebral fractures 55 INVEGA ™ 55 BrachySil TM 55 Rilonacept 55 Acute Ischemic Stroke 55 CERVARIX R 55 clobazam 55 intensive lipid lowering 55 figitumumab 55 Mirapexin 55 efficacy 55 faropenem 55 LEUKINE 55 topical formulations 55 GSK# [001] 55 pancreatic enzyme replacement 55 Clonicel 55 GED aPC 55 cGMPs 55 DSMB 55 oseltamivir resistance 55 hemorrhagic complications 55 Nebido 55 linear pharmacokinetics 55 anticholinergic effects 55 TNF blocker 55 rotigotine transdermal patch 55 Cariprazine 55 Abatacept 55 venous thromboembolic events 55 clomipramine 55 Raptiva R 55 lasofoxifene 55 VIIBRYD 55 ZYVOX 55 Sitagliptin 55 Reclast Aclasta 55 KL4 surfactant 55 insulin sensitizing 55 deferiprone 55 JANUVIA 55 heparins 55 ß blockers 55 Asclera 55 imatinib resistance 55 Voraxaze 55 ARCALYST ® 55 Rasagiline 55 catheter securement 55 GLASSIA 55 ipratropium bromide 55 AGILECT R 55 IV bisphosphonates 55 tocilizumab 55 Sanvar 55 CELVAPAN H#N# 55 anakinra 55 Prilosec omeprazole 55 GEM OS1 55 leukotriene receptor antagonists 55 POSIDUR TM 55 Fludara ® 55 Ventavis ® 55 acamprosate calcium 55 Pazopanib 55 Targretin 55 biomarker identification 55 darbepoetin alfa Aranesp 55 midstage clinical 55 paroxetine sertraline 55 Pfizer Aricept 55 acamprosate 55 venlafaxine Effexor 55 Cinryze ™ 55 EQUETRO 55 interferon gamma 1b 55 ADVEXIN therapy 55 tibolone 55 hematologic toxicity 55 ALTACE 55 desvenlafaxine 55 hERG 55 sargramostim 55 elective PCI 55 torsade de pointes 55 FOSRENOL ® 55 immunological responses 55 Aggrastat ® tirofiban hydrochloride 55 IGIV 55 Mycamine 55 dose titration 55 docetaxel Taxotere ® 55 atypical antipsychotics 55 AZILECT 55 mild hepatic impairment 55 Erythropoietic therapies may 55 tumor lysis syndrome 55 investigational humanized monoclonal antibody 55 antiepileptic drugs AEDs 55 Pristiq desvenlafaxine 55 5 lipoxygenase inhibitor 55 RE LY 55 anticonvulsant medication 55 CoFactor 55 TOPAMAX ® 55 hypoglycemic events 55 preclinically 55 Vascular Wrap TM 55 Primary endpoints 55 AGGRASTAT ® 55 Hypersensitivity reactions 55 dalbavancin 55 pharmacokinetic PK profile 55 Tekturna HCT 55 olanzapine Zyprexa 55 thromboembolic 55 perfusion MRI 55 Subpart H 55 ROTATEQ 55 Tekturna ® 55 DLTs 55 rosuvastatin Crestor 55 systemically absorbed 55 Fondaparinux 55 bioresearch monitoring 55 Limbrel 55 CYCLOSET 55 Dapagliflozin 55 antiandrogens 55 Proellex TM 55 PDE inhibitors 55 lipid lowering therapies 55 Committee IDMC 55 Noxafil 55 Angiox ® 55 thienopyridine 55 oral FTY# 55 hypomethylating agents 55 delafloxacin 55 Calcitonin 55 Menaflex device 55 HPA axis 55 hyperbilirubinemia 55 dosing frequency 55 warfarin therapy 55 Abilify aripiprazole 55 Trobalt 55 romiplostim 55 Vandetanib 55 daptomycin 55 FDA Investigational Device 55 sequestered naltrexone 55 BROVANA 55 adrenal insufficiency 55 Elocalcitol 55 haloperidol Haldol 55 Zarnestra 55 oral anticoagulant therapy 55 hematologic parameters 55 TEMODAL 55 TAXUS Stent 55 nabilone 55 Zoraxel 55 pregabalin Lyrica 55 Intuniv 55 Tumor Response 55 Vorinostat 55 spinal manipulative 55 Mitigation Strategies REMS 55 torsades de pointes 55 Eli Lilly Cymbalta 55 platelet inhibitor 55 PROCRIT ® 55 pharmacologic therapies 55 ponatinib 55 Gralise 55 L PPDS 55 nonrandomized 55 PREZISTA 55 Cerashield 55 randomized trials 55 therapeutic regimens 55 ezetimibe simvastatin 55 immunomodulatory therapy 55 valvulopathy 55 Oral bisphosphonates 55 rimonabant Acomplia 55 hypercholesterolaemia 55 hepatotoxic 55 Aplenzin 55 Ticagrelor 55 sorafenib Nexavar 55 protease inhibitor PI 55 renal anemia 55 supine hypertension 55 atorvastatin Lipitor 55 tigecycline 55 Tracleer ® 55 Xelox 55 neuroprotective properties 55 SUSTENNA TM 55 lipid parameters 55 Neulasta ® 55 CIMZIA TM certolizumab pegol 55 pharmacodynamic PD 55 micafungin 55 anticancer treatments 55 Levaquin levofloxacin 55 chronic idiopathic thrombocytopenic purpura 55 Vidofludimus 55 Kynapid 55 aldosterone antagonist 55 hyperkalemia 55 anticoagulant warfarin 55 opioid prescribing 55 ixabepilone 55 Hypotension 55 postoperative AF 55 hepatic insufficiency 55 thrombophilia 55 FRAGMIN R 55 opportunistic fungal infections 55 Huntexil 55 Lymphoseek ® 55 HepaGam B TM 55 EGFR antibodies 55 NP2 Enkephalin 55 pharmacodynamic markers 55 rheumatoid arthritis osteoarthritis ankylosing 55 hylan GF 55 bardoxolone methyl 55 DPP4 55 antidiabetic 55 dextofisopam 55 Bicifadine 55 postoperative atrial fibrillation 55 Protopic 55 vapreotide acetate 55 aplindore 55 Neurostar 55 Combidex 55 migraine prophylaxis 55 plasma pharmacokinetics 55 NAbs 55 NeuroSTAT ® 55 cognitive behavioral therapies 55 CTAP# Capsules 55 endoscopic examinations 55 Orazol 55 Inovelon 55 FROVA